Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
보완 시스템의 치료적 표적화: 희귀 질병에서 유행병까지
Article
[키워드] activate
approved
Atypical
candidate
chronic disease
Clinical treatment
clinical trials
common disease
complement
contribute
COVID-19
COVID-19 disease
death
Defense
disease
disease pathogenesis
Diseases
disorders
dysfunction
dysregulated
Evidence
example
Hemostasis
homeostasis
Host
include
Inflammation
innate immune system
invading pathogens
ischemia-reperfusion injury
killing
microbes
modulation
molecular pattern
multifunctional
Myocardial infarction
neurologic
organ
Organ failure
pandemic coronavirus
paroxysmal nocturnal hemoglobinuria
pathogen-associated molecular patterns
patient group
pharmacological strategy
pharmacological treatment
plasma
PROTECT
rare disease
robust
Sepsis
severe coronavirus disease
stroke
syndrome
systemic inflammatory
targeting
the antibody
Therapies
therapy
Thromboinflammation
tissue damage
tissue regeneration
tissue repair
trauma
treat
treated
Treatment
[DOI] 10.1124/pharmrev.120.000072 PMC 바로가기 [Article Type] Article
[DOI] 10.1124/pharmrev.120.000072 PMC 바로가기 [Article Type] Article